WOONSOCKET, R.I. If you judge CVS Caremark too harshly based solely on the handful of PBM contracts — even if they were some pretty big contracts — it lost in the short-term, as many investors did in the wake of the company’s Nov. 5 earnings call, you’re missing the big picture.
